2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress is organized by Markets and Markets (MnM) Conferences and will be held from Oct 24 - 25, 2019 at Boston, Massachusetts, United States of America.
With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities.
Real-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural, the 2nd Annual Real-World Data and Life Science Analytics Congress will hold discussions on accelerating the adoption of Real-world evidence within the industry while understanding the capabilities of newer technologies for evidence generation. The congress will also address upcoming changes in the regulatory landscape with the recent framework by the FDA.
Our aim for the 2nd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.
• Real-World Evidence Methodologies
• FDA’s new strategic framework for use of real-world evidence
• Applications of Artificial Intelligence & Blockchain for Real-World Data Analysis
• Evaluation of data sources for better patient outcomes
• Accelerating adoption of Real-world evidence in the pharmaceutical industry and across
Who Should Attend:
From pharmaceutical and Biopharmaceutical companies:
Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists, Bio-Statisticians, Epidemiologist, within the following departments:
Real-World Evidence, Health Economics & Outcomes Research, Market Access, Value Access, Clinical Operations, Clinical Development, Center for Observational and Real-World Evidence
Other: Payers, Regulators, Insurance companies
Additional details will be posted as soon as they are available.
|Contact No. :||+9120 48598270
|Registration Type||End Date||Price|
|Solution Provider Delegate Per Person Fee||23 Oct,2019||USD 1499.00|
|Industry - Delegate Per Person Fee||23 Oct,2019||USD 599.00|